Iradimed (IRMD) Tax Provisions (2013 - 2026)

Iradimed (IRMD) has 14 years of Tax Provisions data on file, last reported at $2.0 million in Q1 2026.

• Tax Provisions for Q1 2026 came in at $2.0 million, up 55.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 million (up 26.62% YoY), and the FY2025 annual result was $5.9 million, up 16.66% from the prior year.
• Tax Provisions grew to $2.0 million in Q1 2026 per IRMD's latest filing, from $1.3 million in the prior quarter.
• Over five years, Tax Provisions peaked at $2.6 million in Q4 2023 and troughed at $573295.0 in Q1 2022.
• A 5-year average of $1.3 million and a median of $1.3 million in 2025 frame the typical range for Tax Provisions.
• The sharpest annual moves came in 2022 and 2024: Tax Provisions soared 232.19% in 2022, then slumped 53.31% in 2024.
• A 5-year view of Tax Provisions shows it stood at $1.0 million in 2022, then jumped by 148.93% to $2.6 million in 2023, then tumbled by 53.31% to $1.2 million in 2024, then advanced by 12.65% to $1.3 million in 2025, then soared by 44.66% to $2.0 million in 2026.
• Business Quant data shows IRMD's Tax Provisions at $2.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.7 million in Q3 2025.